Teladoc Health (TDOC) Capital Expenditures (2014 - 2026)

Teladoc Health has disclosed Capital Expenditures across 13 years of filings, most recently posting $28.0 million for Q2 2026.

• In Q2 2026, Capital Expenditures fell 3.37% year-over-year to $28.0 million; the TTM figure through Jun 2026 stood at $122.9 million (up 10.82% YoY), while the FY2025 annual figure was $118.6 million, up 4.68% from the prior year.
• Capital Expenditures came in at $28.0 million for Q2 2026 at Teladoc Health, down from $34.2 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $47.7 million in Q4 2022 to a low of $23.5 million in Q4 2024.
• Average Capital Expenditures over 5 years is $33.1 million, with a median of $31.8 million recorded in 2023.
• Year-over-year, Capital Expenditures jumped 308.1% in 2022 and sank 33.02% in 2024.
• Over 5 years, Capital Expenditures stood at $47.7 million in 2022, then slipped by 26.4% to $35.1 million in 2023, then slumped by 33.02% to $23.5 million in 2024, then surged by 34.82% to $31.7 million in 2025, then decreased by 11.7% to $28.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $28.0 million in Q2 2026, $34.2 million in Q1 2026, and $31.7 million in Q4 2025.